Please login to the form below

Not currently logged in
Email:
Password:

semaglutide

This page shows the latest semaglutide news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk’s semaglutide obesity trial hits the mark

Novo Nordisk’s semaglutide obesity trial hits the mark

Novo Nordisk’ s semaglutide obesity trial hits the mark. The injection helped adults lose up to 13.8% of their body weight in a year. ... Two thirds (65%) of subjects on semaglutide experienced weight loss of 10% or more, compared to 10% with placebo

Latest news

More from news
Approximately 5 fully matching, plus 13 partially matching documents found.

Latest Intelligence

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    Novo Nordisk is also working with another specialist on oral delivery for protein drugs - Emisphere Technologies - that has applied its Eligen technology to develop an oral version of semaglutide, a

  • Deal Watch table for February 2014 Deal Watch table for February 2014

    Development. Semaglutide once weekly, ZP Patch Technology. 115. Andromeda / Teva Pharmaceutical Industries.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CMR

Specialising in medical device market research, our approach is people-centric and we thrive on making connections with clients and research...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics